As a rare differential diagnosis, CMMRD testing may also be indicated in children without cancer who are suspected to have sporadic NF1 or Legius syndrome but in whom no germline NF1 or SPRED1 PV has been identified by comprehensive testing [19, 20]. This evidence concerns the gene NF1 and cancer.